These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23573306)

  • 1. FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.
    Kawakami M; Morita S; Sunohara M; Amano Y; Ishikawa R; Watanabe K; Hamano E; Ohishi N; Nakajima J; Yatomi Y; Nagase T; Fukayama M; Takai D
    Int J Clin Exp Pathol; 2013; 6(4):598-612. PubMed ID: 23573306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.
    Kawakami M; Ishikawa R; Amano Y; Sunohara M; Watanabe K; Ohishi N; Yatomi Y; Nakajima J; Fukayama M; Nagase T; Takai D
    Cancer Sci; 2013 Nov; 104(11):1447-54. PubMed ID: 23931849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.
    Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kaji M
    Lung Cancer; 2012 Jan; 75(1):110-8. PubMed ID: 21689861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.
    Xia D; Chen B; Yang X
    J Clin Lab Anal; 2019 Oct; 33(8):e22973. PubMed ID: 31418948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
    Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
    Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
    EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
    Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
    Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.
    Ahn J; Truesdell P; Meens J; Kadish C; Yang X; Boag AH; Craig AW
    Mol Cancer Res; 2013 Aug; 11(8):952-63. PubMed ID: 23699534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
    Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
    Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.
    Kim MP; Chen Y; Bekele BN; Lopez A; Khanna A; Chen JQ; Spitz MR; Behrens C; Solis L; Wismach M; Ji L; Wistuba II; Roth JA; Katz RL
    Ann Thorac Surg; 2011 Sep; 92(3):1044-50. PubMed ID: 21871297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
    Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
    Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.